Evidence map›Paper›PMID 42747565›Full record

ArticleHernia : the journal of hernias and abdominal wall surgery2026

Botulinum toxin, progressive pneumoperitoneum and RTL closure for ventral hernias secondary to giant omphalocele in children: a 10-patient series.

Mario Javier Peña Garcia, Edgard Efren Lozada-Hernández, Alejandro Alberto Peñarrieta Daher, Jaime Penchyna Grub, Guillermo Jacobo Serrano Meneses, Ricardo Reynoso González, Ivan Vladimir Medina Lopez

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Hernia : the journal of hernias and abdominal wall surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mario Javier Peña GarciaPediatric Surgery, Hospital Infantil de México Federico Gómez, Cuauhtémoc, Ciudad de México, México.ORCID http://orcid.org/0000-0002-7680-7463
Edgard Efren Lozada-HernándezHospital Regional de Alta Especialidad del Bajío, Servicios de salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-BIENESTAR), León, Guanajuato, 37660, México. edgardlozada2@gmail.com.ORCID http://orcid.org/0000-0001-8614-9516
Alejandro Alberto Peñarrieta DaherNeonatal Surgery, Hospital Infantil de México Federico Gómez, Cuauhtémoc, Ciudad de México, México.ORCID http://orcid.org/0009-0000-1871-2442
Jaime Penchyna GrubPediatric Surgery, Hospital Infantil de México Federico Gómez, Cuauhtémoc, Ciudad de México, México.
Guillermo Jacobo Serrano MenesesNeonatal Surgery, Servicios de Salud del Instituto Mexican del Seguro Social para el Bienestar (IMSS-BIENESTAR), Hospital Pediátrico Moctezuma, Ciudad de México, México.ORCID http://orcid.org/0000-0002-7409-2652
Ricardo Reynoso GonzálezGeneral Surgery, Hernia Care, Ciudad Satélite, México.ORCID http://orcid.org/0000-0001-5635-5845
Ivan Vladimir Medina LopezPediatric Surgery, Hospital General Uruapan, Michoacán, México.ORCID http://orcid.org/0009-0009-5266-1904

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis study describes a pediatric strategy to repair complex ventral hernias secondary to giant omphaloceles, avoiding the use of mesh and component separation. The protocol combines prehabilitation with botulinum toxin (BT), selective preoperative progressive pneumoperitoneum (PPP) and midline closure by the reinforced tension line (RTL) technique, with the aim of evaluating its safety, feasibility and medium-term results.

methodsA retrospective, descriptive and multicenter case series was conducted in 10 patients under 18 years of age with ventral hernia secondary to giant omphalocele. All patients received BT; PPP was indicated in patients whose Tanaka index was ≥25%. Surgical closure was performed using the RTL technique, without prosthetic material. Clinical characteristics, dimensions of the defect, use of prehabilitation, complications, hospital stay, follow-up and recurrence were analyzed.

resultsTen patients were included, all of whom were female, with a median age of 3.7 years and a median weight of 12.7 kg. The median defect area was 60 cm². Four patients required progressive pneumoperitoneum. Primary fascial closure was achieved in 100% of cases, without mesh or separation of components. There were no intraoperative complications. The median hospital stay was 6.5 days, and the median follow-up was 19.8 months. No recurrences were documented.

conclusionsThe combined protocol seems safe and technically viable in this initial series. It allowed primary fascial closure without mesh, without separation of components and without recurrences during follow-up. However, these results should be interpreted as preliminary evidence because of the retrospective design, small sample size and absence of a control group.

Indexed as

Abdominal Wound Closure TechniquesBotulinum Toxins, Type AHernia, VentralHerniorrhaphyOmphalocelePneumoperitoneum, ArtificialAdolescentChildChild, PreschoolFeasibility StudiesFemaleHumansInfantLength of StayMaleRecurrenceBotulinum Toxins, Type ABotulinum toxinCase seriesComplex ventral herniaGiant omphalocelePediatric surgeryProgressive pneumoperitoneumReinforced tension line

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.